The potential biomarkers of checkpoint inhibitor immunotherapy in solid malignancies.

e15226Background: Tumor mutational burden (TMB), PDL1 status, microsatellite status (MS), tumor infiltrating lymphocyte, and the microbiome profile are commonly used biomarkers to predict which pat...